A Study of Apalutamide Administered Orally as Whole Tablets and as a Mixture in Applesauce in Healthy Participants
Clinical trial NCT03802682 · COMPLETED
Trial details
- NCT number
- NCT03802682
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2019-04-11
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.